title: Primary Tumor and MEF Cell Isolation to Study Lung Metastasis.
abstract: In breast tumorigenesis, the metastatic stage of the disease poses the greatest threat to the affected individual. Normal breast cells with altered genotypes now possess the ability to invade and survive in other tissues. In this protocol, mouse mammary tumors are removed and primary cells are prepared from tumors. The cells isolated from this procedure are then available for gene profiling experiments. For successful metastasis, these cells must be able to intravasate, survive in circulation, extravasate to distant organs, and survive in that new organ system. The lungs are the typical target of breast cancer metastasis. A set of genes have been discovered that mediates the selectivity of metastasis to the lung. Here we describe a method of studying lung metastasis from a genetically engineered mouse model.. Furthermore, another protocol for analyzing mouse embryonic fibroblasts (MEFs) from the mouse embryo is included. MEF cells from the same animal type provide a clue of non-cancer cell gene expression. Together, these techniques are useful in studying mouse mammary tumorigenesis, its associated signaling mechanisms and pathways of the abnormalities in embryos.
authors.affiliation: Biochemistry and Molecular Biology, Louisiana State University Health Sciences Center.
authors.forename: Shengli
authors.initials: S
authors.lastname: Dong
authors.affiliation: Biochemistry and Molecular Biology, Louisiana State University Health Sciences Center.
authors.forename: Mazvita
authors.initials: M
authors.lastname: Maziveyi
authors.affiliation: Biochemistry and Molecular Biology, Louisiana State University Health Sciences Center; SAlaha@lsuhsc.edu.
authors.forename: Suresh K
authors.initials: SK
authors.lastname: Alahari
mesh_terms: D000818:Animals; D002469:Cell Separation / Q000379:methods*; D004622:Embryo, Mammalian / Q000166:cytology; D005260:Female; D005347:Fibroblasts / Q000166:cytology*; D008175:Lung Neoplasms / Q000473:pathology* / Q000556:secondary*; D008325:Mammary Neoplasms, Experimental / Q000473:pathology*; D051379:Mice; D008822:Mice, Transgenic